After four weeks of treatment, the control animals (given no treatment) displayed a weight gain of 2.7 grams (g) on average, while those given tirzepatide and semaglutide lost on average 15.6 g ...

Tirzepatide has a dual mechanism of action, so it works in multiple ways to support weight management. It’s also significantly less expensive for individuals paying out of pocket.

Eli Lilly stock dips despite strong Q2 results. Read my insights on obesity drug market dominance and why this selloff in LLY may be a buying opportunity.

Experts suggest that tirzepatide’s dual mechanism of action, targeting two metabolic receptors, may explain its superior weight-loss results compared to semaglutide’s single-receptor approach.

A new study reports that mice shed about 20% of their body weight and saw the size of their breast cancer tumors shrink after getting injected with tirzepatide, aka Mounjaro and Zepbound.